FAQ
Apextide provides one-stop, full process services from laboratory research and development to commercialization, including gram scale research and development, process development, clinical stage production, API and formulation production, analytical method development and validation, registration and application support.
Apextide has a mature project management system, advanced facilities and equipment, customer-centric service concept and efficient demand response mechanism.
Apextide's research and development site covers a total area of more than 10,000 square meters, equipped with international advanced research and development and production facilities.
Apextide follows GMP production standards, has a strict quality management system, and carries out multiple levels of quality inspection and control. At the same time fully support FDA, NMPA, EMA certification.
Apextide's peptide synthesis technology platform includes solid-liquid binding synthesis technology, complete sequence solid phase synthesis technology, cyclic peptide and multiple cyclic peptide synthesis technology.
Apextide's oligonucleotide technology platform includes chemical synthesis technology, modified nucleotide synthesis, and high throughput screening technology.
Address
Hangzhou Pharmaceutical Port
Fax
(086) 0571-8672-0235
Copyright 2024 Hangzhou apextide Biomedical Technology Co., LTD